bcg unresponsive disease
Published 5 years ago • 1K plays • Length 14:50Download video MP4
Download video MP3
Similar videos
-
20:53
bcg unresponsive disease: a roadmap for drug development and novel therapies
-
21:28
bcg failure defining and managing difficult patients
-
21:04
bcg unresponsive non-muscle invasive bladder cancer
-
11:45
emerging treatments for bcg unresponsive non-muscle invasive bladder cancer
-
19:31
adaptive immune resistance to intravesical bcg in nmibc: bcg-unresponsive clinical trials
-
26:18
controversies in non-muscle invasive bladder cancer (nmibc): guidelines and beyond 2023
-
10:35
management of bcg unresponsive cystectomy ineligible bladder cancer patients pembrolizumab
-
1:08:14
urowebinar: bcg unresponsive disease how this definition impact your treatment decision making
-
50:41
management of bcg-unresponsive non-muscle invasive bladder cancer
-
9:12
immunotherapy for nmibc: emerging and expanding indications
-
9:21
bcg failure: defining failure and managing difficult cases of non-muscle invasive bladder cancer
-
14:18
barriers to clinical trials for non-muscle invasive bladder cancer
-
11:40
point-counterpoint: muscle invasive bladder cancer–cystectomy perspective
-
53:04
emerging salvage therapies for bcg-unresponsive non-muscle invasive bladder cancer
-
21:10
prioritizing the optimal therapy for t1 bladder cancer: using the old and new
-
15:48
managing nmibc in the bcg shortage era
-
19:31
second line bladder cancer therapies when first line treatments fail
-
15:42
urinary markers in bladder cancer
-
9:12
bcg maintenance should be less intense